Merck & Co Inc (MRK.N) reported a better-than-expected quarterly profit and boosted its full-year earnings forecast as demand for its diabetes and cancer drugs increased. The company also said it […]

At age 45, Allergan Chief Executive Brent Saunders already pulled off something like $150 billion worth of deals. Now he’s going to get ready to do it again. Last year alone Saunders […]

Bristol-Myers Squibb Co on Thursday reported far better than expected quarterly results thanks largely to delayed reimbursement for two hepatitis C treatments in France and demand for other leading company […]